NEW USE OF CELL-PERMEABLE PEPTIDE INHIBITORS OF THE JNK SIGNAL TRANSDUCTION PATHWAY FOR THE TREATMENT OF MILD COGNITIVE IMPAIRMENT

摘要

The present invention refers to the use of protein kinase inhibitors and more specifically to the use of inhibitors of the protein kinase c-Jun N-terminal kinase, JNK inhibitor sequences, chimeric peptides, or of nucleic acids encoding same as well as pharmaceutical compositions containing same, for the prevention and/or treatment of Mild Cognitive Impairment, in particular of Mild Cognitive Impairment due to Alzheimer's Disease.